Nvidia’s portfolio experienced significant declines in the second quarter, with most of its investments taking a hit. Despite this, a substantial portion of Nvidia’s assets has still appreciated since the beginning of the year. The company maintained its shares in Arm, SoundHound AI, Nanox Imaging, and Recursion Pharmaceuticals, but did not alter its holdings. Notably, Arm was the only stock among these investments to see gains, appreciating by approximately 30%. In contrast, Nanox Imaging and Recursion Pharmaceuticals both fell by nearly 25%, while SoundHound AI declined by 32%. Serve Robotics, which Nvidia acquired a stake in, saw its shares plummet to about half their value since its initial public offering (IPO).

Nvidia’s investment in Arm stands out as its most significant stock asset, valued at over $320 million as of late June. Despite the quarterly setbacks, the majority of Nvidia’s holdings have achieved year-to-date gains, with some outperforming the S&P 500 index. SoundHound AI’s stock has more than doubled in value in 2024, mirroring Nvidia’s growth, while Arm surged by 73% and Nano X Imaging rose by 13%. Serve Robotics has nearly tripled in value since its IPO, bolstered by a recent partnership with Shake Shack via Uber Technologies. Conversely, Recursion Pharmaceuticals was the only investment that suffered losses during this period, declining almost 32% since the year began.